---
title: "NHS National Framework for Natalizumab-February 2024"
ocid: "ocds-h6vhtk-040f2f"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-040f2f"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-040f2f.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-040f2f.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "NHS ENGLAND"
published: "2024-02-02"
---

# NHS National Framework for Natalizumab-February 2024

Buyer: NHS ENGLAND  
Current stage: Award  
OCID: ocds-h6vhtk-040f2f

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-040f2f)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-040f2f.json)

## Summary

The NHS England has completed the tender process for the NHS National Framework for Natalizumab, with the award going to Samsung Bioepis UK Ltd, Alexion Pharmaceuticals, and Amgen Ltd. This procurement falls under the goods category, specifically for pharmaceutical products. The tender was initiated as an open procedure with the title "NHS National Framework for Natalizumab-February 2024". The contract value is 1 GBP, signed on 5th January 2024, and involves multiple suppliers. The procurement was managed by the buying organisation NHS England based in Leeds, United Kingdom.

The tender for the NHS National Framework for Eculizumab offers significant business growth opportunities in the pharmaceutical products industry. Companies suited for this tender would be pharmaceutical suppliers of various scales, from SMEs to large corporations. The procurement process is currently active, with a submission deadline set for 27th November 2023. Suppliers are required to submit bids electronically, and the contract period extends from 1st February 2024 to 30th April 2025, with options for further extensions. The NHS England is the contracting authority responsible for overseeing this procurement, aimed at enhancing healthcare service delivery in the UK.

## Notice

Project Title: NHS National Framework Agreement for the supply of Eculizumab - 1 Feb 2024
Offer reference number: CM/PHR/22/5693
Period of framework: 1 February 2024 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

### Lot Information

Lot 1

Project Title: NHS National Framework Agreement for the supply of Eculizumab - 1 Feb 2024
Offer reference number: CM/PHR/22/5693
Period of framework: 1 February 2024 to 30 April 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Options: There will be an option to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/003529-2024 |
| Notice type | Tender Notice |
| Procurement type | Framework |
| Procurement category | Goods |
| Procurement method | Open |
| Procurement method details | Open procedure |
| Tender suitability | Not specified |
| Awardee scale | Large, SME |
| All stages | Tender, Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 2 Feb 2024 |
| Submission deadline | 27 Nov 2023 |
| Future notice date | Not specified |
| Award date | 5 Jan 2024 |
| Contract period | 1 Feb 2024 - 30 Apr 2025 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | £122,287,000 |
| Lots value | £122,287,000 |
| Awards value | Not specified |
| Contracts value | £1 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Cancelled |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | NHS ENGLAND |
| Locality | LEEDS |
| Post town | Leeds |
| Postcode | LS2 7UE |
| Country | England |
| ITL 1 | TLE Yorkshire and The Humber |
| ITL 2 | TLE4 West Yorkshire |
| ITL 3 | TLE42 Leeds |
| Local authority | Leeds |
| Electoral ward | Little London & Woodhouse |
| Westminster constituency | Leeds Central and Headingley |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 3 |
| Supplier names | ALEXION PHARMACEUTICALS; AMGEN; SAMSUNG BIOEPIS |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 2 Feb 2024 at 13:05 - Award - Award Notice - https://www.find-tender.service.gov.uk/Notice/003529-2024
- 26 Oct 2023 at 10:32 - Tender - Tender Notice - https://www.find-tender.service.gov.uk/Notice/031590-2023

## Notice URLs

- http://health.atamis.co.uk
- https://health-family.force.com/s/Welcome
- https://supplierregistration.cabinetoffice.gov.uk
- https://www.england.nhs.uk/
- https://www.england.nhs.uk//
- https://www.judiciary.uk/courts-and-tribunals/high-court/

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-040f2f. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-040f2f.json.